US Stock MarketDetailed Quotes

XPER Xperi

Watchlist
  • 7.990
  • -0.040-0.50%
Close Mar 21 16:00 ET
  • 7.990
  • 0.0000.00%
Post 16:13 ET
363.69MMarket Cap-25.77P/E (TTM)

Xperi Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-89,358.06%-55.34M
-94.05%1.23M
-119.34%-4.65M
-39.84%-2.13M
-15.51%-49.79M
100.22%62K
220.74%20.66M
120.03%24.03M
60.77%-1.53M
-134.71%-43.1M
Net income from continuing operations
99.38%-869K
348.74%62.96M
52.86%-19.83M
22.19%-30.63M
59.41%-13.37M
81.65%-139.69M
91.51%-25.31M
89.53%-42.07M
-27.07%-39.36M
-8.03%-32.94M
Operating gains losses
---95.99M
---73.06M
--0
--0
---22.93M
----
----
----
----
----
Depreciation and amortization
-24.71%56.01M
-24.48%13.22M
-26.99%13.85M
-24.63%14.32M
-22.71%14.62M
-10.05%74.4M
-16.03%17.51M
-12.18%18.97M
-4.55%19M
-7.05%18.92M
Deferred tax
65.88%-2.93M
60.40%-3M
66.08%-97K
88.81%-60K
211.50%223K
7.18%-8.6M
14.03%-7.57M
36.59%-286K
-182.11%-536K
-205.26%-200K
Other non cash items
-348.93%-1.86M
-39.78%548K
-617.54%-409K
-109.41%-2.31M
-68.70%313K
3,016.67%748K
435.29%910K
94.70%-57K
-182.22%-1.11M
341.55%1M
Change In working capital
-3,761.84%-71.77M
-197.25%-16.21M
-144.93%-13.41M
-47.74%1.25M
7.56%-43.4M
14.89%1.96M
427.23%16.67M
6.79%29.85M
152.94%2.39M
-182.12%-46.95M
-Change in receivables
-279.15%-51.81M
187.88%261K
-599.30%-27.14M
-175.47%-10.09M
1.97%-14.85M
-371.56%-13.67M
97.96%-297K
-62.51%5.44M
70.84%-3.66M
-185.70%-15.14M
-Change in prepaid assets
310.65%11.07M
346.02%6.39M
-242.41%-225K
12.94%7.7M
51.16%-2.79M
113.19%2.7M
125.78%1.43M
101.55%158K
--6.82M
---5.71M
-Change in payables and accrued expense
-423.85%-28.37M
-276.38%-20.99M
-20.88%17.39M
1,692.31%2.48M
-9.15%-27.25M
-65.54%8.76M
-24.37%11.9M
-14.67%21.98M
-101.69%-156K
1.42%-24.96M
-Change in other working capital
-163.93%-2.67M
-151.39%-1.87M
-250.61%-3.43M
288.85%1.15M
230.89%1.48M
150.23%4.17M
624.24%3.63M
206.79%2.28M
-27.88%-610K
77.33%-1.13M
Cash from discontinued investing activities
Operating cash flow
-89,358.06%-55.34M
-94.05%1.23M
-119.34%-4.65M
-39.84%-2.13M
-15.51%-49.79M
100.22%62K
220.74%20.66M
120.03%24.03M
60.77%-1.53M
-134.71%-43.1M
Investing cash flow
Cash flow from continuing investing activities
492.95%50.82M
1,999.85%63.68M
-30.69%-4.42M
-64.27%-3.73M
-19.98%-4.71M
80.06%-12.93M
10.59%-3.35M
93.72%-3.38M
20.57%-2.27M
9.99%-3.93M
Capital expenditure reported
-97.45%-11.72M
-108.37%-2.54M
-211.34%-3.35M
-84.75%-3.22M
-37.43%-2.6M
-437.41%-5.93M
---1.22M
---1.08M
---1.74M
---1.89M
Net PPE purchase and sale
26.00%-5.04M
17.07%-1.74M
55.65%-997K
8.15%-462K
6.20%-1.85M
47.99%-6.82M
19.00%-2.1M
33.17%-2.25M
82.07%-503K
54.73%-1.97M
Net intangibles purchase and sale
-5.41%-195K
-5.56%-38K
-25.86%-73K
-95.65%-45K
42.65%-39K
-11.45%-185K
35.71%-36K
-56.76%-58K
56.60%-23K
-240.00%-68K
Net business purchase and sale
--67.77M
--68M
--0
--0
---227K
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
492.95%50.82M
1,999.85%63.68M
-30.69%-4.42M
-64.27%-3.73M
-19.98%-4.71M
80.06%-12.93M
10.59%-3.35M
93.72%-3.38M
20.57%-2.27M
9.99%-3.93M
Financing cash flow
Cash flow from continuing financing activities
-374.39%-19.35M
-227.54%-7.03M
-803.46%-10.72M
-45.57%3.07M
-60.13%-4.67M
-94.81%7.05M
2,028.32%5.52M
-101.29%-1.19M
-69.31%5.64M
-111.33%-2.92M
Net common stock issuance
---19.99M
---9.99M
----
----
----
--0
--0
----
----
----
Proceeds from stock option exercised by employees
-34.14%7.86M
-41.96%3.53M
--0
----
----
--11.93M
--6.08M
--0
----
----
Net other financing activities
-48.00%-7.22M
-1.42%-570K
39.63%-716K
-499.05%-1.26M
-60.13%-4.67M
-109.28%-4.88M
99.33%-562K
-101.29%-1.19M
-101.14%-210K
-111.33%-2.92M
Cash from discontinued financing activities
Financing cash flow
-374.39%-19.35M
-227.54%-7.03M
-803.46%-10.72M
-45.57%3.07M
-60.13%-4.67M
-94.81%7.05M
2,028.32%5.52M
-101.29%-1.19M
-69.31%5.64M
-111.33%-2.92M
Net cash flow
Beginning cash position
-3.56%154.43M
-44.74%72.69M
-17.54%92.48M
-13.98%95.22M
-3.56%154.43M
32.67%160.13M
-26.98%131.53M
-15.83%112.16M
-10.25%110.7M
32.67%160.13M
Current changes in cash
-310.21%-23.87M
153.58%57.88M
-201.65%-19.78M
-251.46%-2.79M
-18.46%-59.17M
-113.70%-5.82M
207.93%22.82M
-60.24%19.46M
-84.14%1.84M
-1,751.21%-49.95M
Effect of exchange rate changes
--0
--0
86.81%-12K
115.22%58K
-108.88%-46K
104.16%126K
-93.08%80K
95.65%-91K
77.68%-381K
234.55%518K
End cash Position
-15.46%130.56M
-15.46%130.56M
-44.74%72.69M
-17.54%92.48M
-13.98%95.22M
-3.56%154.43M
-3.56%154.43M
-26.98%131.53M
-15.83%112.16M
-10.25%110.7M
Free cash flow
-461.67%-72.29M
-117.84%-3.09M
-143.92%-9.07M
-54.45%-5.86M
-15.40%-54.27M
69.94%-12.87M
182.97%17.31M
174.57%20.65M
43.75%-3.8M
-106.93%-47.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -89,358.06%-55.34M-94.05%1.23M-119.34%-4.65M-39.84%-2.13M-15.51%-49.79M100.22%62K220.74%20.66M120.03%24.03M60.77%-1.53M-134.71%-43.1M
Net income from continuing operations 99.38%-869K348.74%62.96M52.86%-19.83M22.19%-30.63M59.41%-13.37M81.65%-139.69M91.51%-25.31M89.53%-42.07M-27.07%-39.36M-8.03%-32.94M
Operating gains losses ---95.99M---73.06M--0--0---22.93M--------------------
Depreciation and amortization -24.71%56.01M-24.48%13.22M-26.99%13.85M-24.63%14.32M-22.71%14.62M-10.05%74.4M-16.03%17.51M-12.18%18.97M-4.55%19M-7.05%18.92M
Deferred tax 65.88%-2.93M60.40%-3M66.08%-97K88.81%-60K211.50%223K7.18%-8.6M14.03%-7.57M36.59%-286K-182.11%-536K-205.26%-200K
Other non cash items -348.93%-1.86M-39.78%548K-617.54%-409K-109.41%-2.31M-68.70%313K3,016.67%748K435.29%910K94.70%-57K-182.22%-1.11M341.55%1M
Change In working capital -3,761.84%-71.77M-197.25%-16.21M-144.93%-13.41M-47.74%1.25M7.56%-43.4M14.89%1.96M427.23%16.67M6.79%29.85M152.94%2.39M-182.12%-46.95M
-Change in receivables -279.15%-51.81M187.88%261K-599.30%-27.14M-175.47%-10.09M1.97%-14.85M-371.56%-13.67M97.96%-297K-62.51%5.44M70.84%-3.66M-185.70%-15.14M
-Change in prepaid assets 310.65%11.07M346.02%6.39M-242.41%-225K12.94%7.7M51.16%-2.79M113.19%2.7M125.78%1.43M101.55%158K--6.82M---5.71M
-Change in payables and accrued expense -423.85%-28.37M-276.38%-20.99M-20.88%17.39M1,692.31%2.48M-9.15%-27.25M-65.54%8.76M-24.37%11.9M-14.67%21.98M-101.69%-156K1.42%-24.96M
-Change in other working capital -163.93%-2.67M-151.39%-1.87M-250.61%-3.43M288.85%1.15M230.89%1.48M150.23%4.17M624.24%3.63M206.79%2.28M-27.88%-610K77.33%-1.13M
Cash from discontinued investing activities
Operating cash flow -89,358.06%-55.34M-94.05%1.23M-119.34%-4.65M-39.84%-2.13M-15.51%-49.79M100.22%62K220.74%20.66M120.03%24.03M60.77%-1.53M-134.71%-43.1M
Investing cash flow
Cash flow from continuing investing activities 492.95%50.82M1,999.85%63.68M-30.69%-4.42M-64.27%-3.73M-19.98%-4.71M80.06%-12.93M10.59%-3.35M93.72%-3.38M20.57%-2.27M9.99%-3.93M
Capital expenditure reported -97.45%-11.72M-108.37%-2.54M-211.34%-3.35M-84.75%-3.22M-37.43%-2.6M-437.41%-5.93M---1.22M---1.08M---1.74M---1.89M
Net PPE purchase and sale 26.00%-5.04M17.07%-1.74M55.65%-997K8.15%-462K6.20%-1.85M47.99%-6.82M19.00%-2.1M33.17%-2.25M82.07%-503K54.73%-1.97M
Net intangibles purchase and sale -5.41%-195K-5.56%-38K-25.86%-73K-95.65%-45K42.65%-39K-11.45%-185K35.71%-36K-56.76%-58K56.60%-23K-240.00%-68K
Net business purchase and sale --67.77M--68M--0--0---227K--0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow 492.95%50.82M1,999.85%63.68M-30.69%-4.42M-64.27%-3.73M-19.98%-4.71M80.06%-12.93M10.59%-3.35M93.72%-3.38M20.57%-2.27M9.99%-3.93M
Financing cash flow
Cash flow from continuing financing activities -374.39%-19.35M-227.54%-7.03M-803.46%-10.72M-45.57%3.07M-60.13%-4.67M-94.81%7.05M2,028.32%5.52M-101.29%-1.19M-69.31%5.64M-111.33%-2.92M
Net common stock issuance ---19.99M---9.99M--------------0--0------------
Proceeds from stock option exercised by employees -34.14%7.86M-41.96%3.53M--0----------11.93M--6.08M--0--------
Net other financing activities -48.00%-7.22M-1.42%-570K39.63%-716K-499.05%-1.26M-60.13%-4.67M-109.28%-4.88M99.33%-562K-101.29%-1.19M-101.14%-210K-111.33%-2.92M
Cash from discontinued financing activities
Financing cash flow -374.39%-19.35M-227.54%-7.03M-803.46%-10.72M-45.57%3.07M-60.13%-4.67M-94.81%7.05M2,028.32%5.52M-101.29%-1.19M-69.31%5.64M-111.33%-2.92M
Net cash flow
Beginning cash position -3.56%154.43M-44.74%72.69M-17.54%92.48M-13.98%95.22M-3.56%154.43M32.67%160.13M-26.98%131.53M-15.83%112.16M-10.25%110.7M32.67%160.13M
Current changes in cash -310.21%-23.87M153.58%57.88M-201.65%-19.78M-251.46%-2.79M-18.46%-59.17M-113.70%-5.82M207.93%22.82M-60.24%19.46M-84.14%1.84M-1,751.21%-49.95M
Effect of exchange rate changes --0--086.81%-12K115.22%58K-108.88%-46K104.16%126K-93.08%80K95.65%-91K77.68%-381K234.55%518K
End cash Position -15.46%130.56M-15.46%130.56M-44.74%72.69M-17.54%92.48M-13.98%95.22M-3.56%154.43M-3.56%154.43M-26.98%131.53M-15.83%112.16M-10.25%110.7M
Free cash flow -461.67%-72.29M-117.84%-3.09M-143.92%-9.07M-54.45%-5.86M-15.40%-54.27M69.94%-12.87M182.97%17.31M174.57%20.65M43.75%-3.8M-106.93%-47.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
+14.85%
New Fortress Energy
NFE
+7.92%
Cars.com
CARS
+2.11%
Halozyme Therapeutics
HALO
+1.31%
Collegium Pharmaceutical
COLL
+0.40%

Unlock the Full List